A phase II clinical trial in patients with metastatic melanoma comparing autologous dendritic cells pulsed with autologous tumour peptides and melanoma associated peptides linked to the endoplasmic re (1999–2000)

Abstract:
A phase II clinical trial in patients with metastatic melanoma comparing autologous dendritic cells pulsed with autologous tumour peptides and melanoma associated peptides linked to the endoplasmic reticulum signal sequence
Grant type:
Queensland Cancer Fund
Researchers:
Funded by:
Queensland Cancer Fund